BioCentury
ARTICLE | Company News

AmDerma Pharmaceuticals LLC, Oculus deal

February 21, 2011 8:00 AM UTC

Oculus granted AmDerma an option to license Oculus' Microcyn technology for $500,000 for a yet to be determined formulation to treat acne. If AmDerma exercises its option, Oculus will receive an undi...